Should pimobendan always be used in congenital heart failure in dog and cats?
Journal: Journal of Advances in VetBio Science and Techniques (Vol.2, No. 2)Publication Date: 2017-08-31
Authors : Songül Toplu; Kerem Ural; Sezen Doğan;
Page : 24-29
Keywords : Pimobendan; Cat; Dog; Congestive heart failure;
Abstract
Pimobendan has a positive inotropic and vasodilatory effect by sensitization of calcium and inhibiton of phosphodiesterase III enzyme. It is widely used for treatment of congestive heart failure from chronic valvular disease or dilated cardiomyopathy both human and veterinary medicine. Positive findings have advised about pimobendan association with increasing life quality, reducing heart failure score and increasing survival time, however, potential side effects also available. Studies of pimobendan uses in cats are underway to further assess. Therefore, it can be suggested that safe use of pimobendan is not inconvenient unless it is used except in indications.
Other Latest Articles
- Production and Marketing Problems of Cattle Enterpreneurs: The Case Of Aksaray Province
- Evaluation of Linear Type Traits in Aberdeen Angus Breed Cows from Uruguay
- Developments in the use of environmental taxes in Algeria
- Samples in social sciences and methods of withdrawing
- Using external audit to reduce the impact of creative accounting when adopting corporate governance
Last modified: 2021-01-31 06:04:40